Company: AIP
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048977
Chunk: 251

Company: Arteris, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 251
---
 that current conditions as of the balance sheet date do not change for the remaining life of current accounts receivable and contract assets. This ASU is effective for fiscal years beginning after December 15, 2025 and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures, which requires incremental disclosures to disaggregate certain income statement expense line items on an annual and interim basis. ASU 2024-03, as clarified by ASU 2025-01, is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting these ASUs on its consolidated financial statements and disclosures.

3.    REVENUE

Disaggregated RevenueThe following table shows revenue by product and services groups (in thousands):Three Months EndedSeptember 30,Nine Months EndedSeptember 30,2025202420252024Licensing, support and maintenance$15,896 $13,507 $46,319 $38,799 Variable royalties1,505 1,176 4,074 2,965 Other7 30 49 471 Total$17,408 $14,713 $50,442 $42,235 Contract BalancesThe following table provides information about accounts receivable, net, contract assets and deferred revenue (in thousands):As ofSeptember 30,2025December 31,2024Accounts receivable, net$16,480 $20,608 Contract assets, current portion$— $167 Deferred revenue$85,872 $75,622 The Company recognized revenue of $13.6 million and $12.3 million for the three months ended September 30, 2025 and 2024, respectively, and $35.4 million and $28.9 million for the nine months ended September 30, 2025 and 2024, respectively, that was included in the deferred revenue balance at the beginning of the respective periods. Contract assets,